Antoni Gelabert-Más
- Urology top 1%
- Pulmonary and Respiratory Medicine top 10%
- Surgery
- Rheumatology top 10%
- Molecular Biology
- Co-authors
- Octavio ArangoÓscar BielsaJoan CarlesJ. PlacerJosep Maria Manresa‐DomínguezJosé A. LorenteJ. CorominasJoan C. Vilanova
- Topics
- Prostate Cancer Diagnosis and Treatment (10 papers)Urological Disorders and Treatments (9 papers)Renal cell carcinoma treatment (7 papers)
- Journals
- The Journal of UrologyInternational Journal of Radiation Oncology*Biology*PhysicsEuropean Urology
- Partner nations
- Spain
In The Last Decade
Antoni Gelabert-Más
38 papers receiving 519 citations
Peers
Comparison fields: 5 of 52
- Urology 274
- Pulmonary and Respiratory Medicine 271
- Surgery 248
- Rheumatology 155
- Molecular Biology 64
Countries citing papers authored by Antoni Gelabert-Más
This map shows the geographic impact of Antoni Gelabert-Más's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoni Gelabert-Más with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoni Gelabert-Más more than expected).
Fields of papers citing papers by Antoni Gelabert-Más
This network shows the impact of papers produced by Antoni Gelabert-Más. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoni Gelabert-Más. The network helps show where Antoni Gelabert-Más may publish in the future.
Co-authorship network of co-authors of Antoni Gelabert-Más
This figure shows the co-authorship network connecting the top 25 collaborators of Antoni Gelabert-Más. A scholar is included among the top collaborators of Antoni Gelabert-Más based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoni Gelabert-Más. Antoni Gelabert-Más is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 117 | |
| 3 | 4 | |
| 4 | 5 | |
| 5 | 13 | |
| 6 | 5 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 35 | |
| 12 | 1 | |
| 13 | 17 | |
| 14 | 10 | |
| 15 | 2 | |
| 16 | 1 | |
| 17 | 15 | |
| 18 | 13 | |
| 19 | 1 | |
| 20 | [A prospective and randomized study of the complete response, index of recurrences and progression in superficial bladder carcinoma treated with mitomycin C alone versus mitomycin C and BCG alternatively]. | 2 |
About Antoni Gelabert-Más
Antoni Gelabert-Más is a scholar working on Urology, Obstetrics and Gynecology and Rheumatology, having authored 40 papers that have together received 535 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (10 papers), Urological Disorders and Treatments (9 papers) and Renal cell carcinoma treatment (7 papers). The work is most often cited by research in Urology (274 citations), Rheumatology (155 citations) and Pulmonary and Respiratory Medicine (271 citations). Antoni Gelabert-Más has collaborated with scholars based in Spain. Frequent co-authors include Octavio Arango, Óscar Bielsa, Joan Carles, J. Placer, Josep Maria Manresa‐Domínguez, José A. Lorente, J. Corominas, Joan C. Vilanova, C. Barceló‐Vidal and Josep Comet. Their work appears in journals such as The Journal of Urology, International Journal of Radiation Oncology*Biology*Physics and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.